Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Antimicrobial Resistance to Linezolid

Venkata G. Meka and Howard S. Gold
Clinical Infectious Diseases
Vol. 39, No. 7 (Oct. 1, 2004), pp. 1010-1015
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4462839
Page Count: 6
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Antimicrobial Resistance to Linezolid
Preview not available

Abstract

Acquired resistance to linezolid, the first approved oxazolidinone, has been selected in laboratory experiments and has been observed in clinical isolates of gram-positive cocci. This resistance has typically been associated with single-nucleotide changes in varying numbers of copies of the genes encoding 23S ribosomal RNA. In the current environment of increasingly prevalent resistance to standard antibiotics, linezolid is an important drug because of its activity against a number of clinically significant gram-positive cocci, including multidrug-resistant staphylococci and enterococci. Although resistance to linezolid remains uncommon, the development of resistance by clinical isolates should prompt increased attention to susceptibility testing for this agent and should be taken into account in consideration of the therapeutic use of this drug.

Page Thumbnails

  • Thumbnail: Page 
1010
    1010
  • Thumbnail: Page 
1011
    1011
  • Thumbnail: Page 
1012
    1012
  • Thumbnail: Page 
1013
    1013
  • Thumbnail: Page 
1014
    1014
  • Thumbnail: Page 
1015
    1015